Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; magnetic resonance imaging; image-guided biopsy; diagnostic imaging; risk; CS; clinically significant; DRE; digital rectal examination; FBx; MRI/TRUS fusion-guided biopsy; mpMRI; multiparametric MRI; MRI; magnetic resonance imaging; P
مقالات ISI آنتی ژن اختصاصی پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; neoplasm staging; practice guidelines as topic; guideline adherence; ADT; androgen deprivation therapy; APC; advanced prostate cancer; CRPC; castration resistant prostate cancer; EMR; electronic medical record; IUOGP; integrated urolo
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; organ specificity; prostate-specific antigen; nomograms; neoplasm grading; BCR; biochemical recurrence; CZ; central zone; EPS; extraprostatic spread; IDCP; intraductal carcinoma; ISUP; International Society of Urological Pathology; PS
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; watchful waiting; prostatectomy; prostate-specific antigen; neoplasm grading; AS; active surveillance; BCR; biochemical recurrence; bRFS; BCR-free survival; GR; grade reclassification; GS; Gleason score; IRP; immediate radical prostat
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostatic intraepithelial neoplasia; biopsy; quality improvement; diagnosis; ASAP; atypical small acinar proliferation; BCBSM; Blue Cross Blue Shield of Michigan; DRE; digital rectal examination; HGPIN; high grade prostatic intraepith
Keywords: آنتی ژن اختصاصی پروستات; prostate; prostate-specific antigen; 5-alpha reductase inhibitors; alopecia; dihydrotestosterone; 5aR; 5α-reductase; 5aRI; 5aR inhibitor; BPH; benign prostatic hyperplasia; PSA; prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; prostate; prostatectomy; margins of excision; surgeons; quality improvement; ACS-NSQIP®; American College of Surgeons National Surgical Quality Improvement Program®; CQPR; comparative quality performance review; NCCN®; National Comprehensive Cancer Ne
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; sentinel surveillance; epidemiology; risk factors; mortality; ACM; all cause mortality; AS; active surveillance; mpMRI; multiparametric magnetic resonance imaging; MSKCC; Memorial Sloan Kettering Cancer Center; NCCN®; National Compr
Keywords: آنتی ژن اختصاصی پروستات; preventive health services; early detection of cancer; prostate-specific antigen; surveys and questionnaires; HINTS; Health Information National Trends Survey; PSA; prostate specific antigen; USPSTF; U.S. Preventive Services Task Force;
Keywords: آنتی ژن اختصاصی پروستات; BPH; Benign Prostatic Hyperplasia; IGF-1; insulin like growth factor-1; IGFBP-3; insulin like growth factor binding protein - 3; HOMA-IR; homeostasis model assessment of insulin resistance; Benign Prostatic Hyperplasia; Insulin; Insulin like growth fact
Keywords: آنتی ژن اختصاصی پروستات; prostatic hyperplasia; prostatectomy; robotics; lasers; solid-state; outcome assessment (health care); BPH; benign prostatic hyperplasia; CV; catheterization; Hb; hemoglobin; HoLEP; holmium laser enucleation of prostate; LOS; length of stay; LUTS; lower u
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostatectomy; robotic surgical procedures; salvage therapy; surveys and questionnaires; AS; active surveillance; BCR; biochemical recurrence; EBL; estimated blood loss; FT; focal therapy; ICSmaleIS; International Continence Society m
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; androgen antagonists; antineoplastic agents; hormonal; drug related side effects and adverse reactions; risk; ADT; androgen deprivation therapy; AMI; acute myocardial infarction; CADT; continuous ADT; GnRH; gonadotropin-releasing horm
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostate-specific antigen; watchful waiting; African continental ancestry group; Caribbean region; AS; active surveillance; BCR; biochemical recurrence; CAPRA-S; Cancer of the Prostate Risk Assessment Postsurgical; DRE; digital rectal
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostatectomy; neoplasm metastasis; castration; mortality; CSS; cancer specific survival; OS; overall survival; PCa; prostate cancer; pN+; pathological node positive; PSA; prostate specific antigen; RRP; radical retropubic prostatecto
Keywords: آنتی ژن اختصاصی پروستات; prostatic hyperplasia; laser therapy; learning curve; mentors; urinary incontinence; BPH; benign prostatic hyperplasia; CD; case difficulty; GMP; grossly multinodular prostate; HoLEP; holmium laser enucleation of prostate; LCC; learning curve characteriza
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; neoplasm recurrence; local; androgen antagonists; salvage therapy; mortality; ADT; androgen deprivation therapy; AUA; American Urological Association; PSA; prostate specific antigen; SADT; salvage androgen deprivation therapy; TOAD;
Keywords: آنتی ژن اختصاصی پروستات; biopsy; China; early detection of cancer; prostatic neoplasms; prostate-specific antigen; DRE; digital rectal examination; Durham VA; Durham Veteran Affairs Hospital; ERSPC; European Randomized Study of Screening for Prostate Cancer; HGPCa; high grade pro
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostatectomy; lymph node excision; lymphatic metastasis; mortality; ADT; androgen deprivation therapy; CCI; Charlson comorbidity index; ECOG; Eastern Cooperative Oncology Group; LN; lymph node; NCDB; National Cancer Database; OS; ove
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; obesity; watchful waiting; prostatectomy; risk factors; AS; active surveillance; BMI; body mass index; GS; Gleason score; JHH; Johns Hopkins Hospital; MRI; magnetic resonance imaging; MSKCC; Memorial Sloan Kettering Cancer Center; PCa
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostate-specific antigen; androgen antagonists; delayed-action preparations; calcium sulfate; 2D; 2-dimensional; 2-HOF; 2-hydroxyflutamide; ADC; apparent diffusion coefficient; Cho; choline; Cit; citrate; Cr; creatine; DWI; diffusion
Keywords: آنتی ژن اختصاصی پروستات; decision support systems; clinical; prostatic neoplasms; prostate-specific antigen; AA; African American; AUA; American Urological Association; DA; decision aid; FG; focus group; PSA; prostate specific antigen; SDM; shared decision making; USPSTF; U.S. Pr
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; biomarkers; cancer; biopsy; neoplasm recurrence; local; watchful waiting; BCR; biochemical relapse; CHUM; Centre hospitalier de l'Université de Montréal; NCCN®; National Comprehensive Cancer Network®; PSA; prostate specific anti
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; biopsy; iatrogenic disease; infection; complications; BPH; benign prostatic hyperplasia; PNBx; prostate needle biopsy; PSA; prostate specific antigen; SPARCS; New York Statewide Planning and Research Cooperative System; USPSTF; United
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; photochemotherapy; WST11 compound; therapeutic occlusion; treatment outcome; AS; active surveillance; CSC; clinically significant cancer; FT; focal therapy; HIFU; high intensity focused ultrasound; IIEF; International Index of Erectil
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; testosterone; prostate-specific antigen; leuprolide; mortality; ADT; androgen deprivation therapy; CAD; continuous androgen deprivation; CRPC; castration resistant prostate cancer; CSS; cause specific survival; IAD; intermittent andro
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; biopsy; magnetic resonance imaging; diagnostic imaging; standards; CCF; Cleveland Clinic Foundation; DCE; dynamic contrast enhanced T1-weighted imaging; DWI; diffusion-weighted imaging; GG; grade group; JHH; Johns Hopkins Hospital; mp
Keywords: آنتی ژن اختصاصی پروستات; Aptamer; Prostate specific antigen; Electrochemical impedance spectroscopy; Label free detection; Multiwalled carbon nanotubes;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; SEER program; watchful waiting; prostate-specific antigen; AS; active surveillance; DT; definitive therapy; EM; expectant management; PCa; prostate cancer; PSA; prostate specific antigen; T-stage; tumor stage; U.S.; United States;
Keywords: آنتی ژن اختصاصی پروستات; prostatectomy; prostate-specific antigen; monitoring; physiologic; follow-up studies; recurrence; BCR; biochemical recurrence; PSA; prostate specific antigen; PSA-DT; PSA doubling time;
Keywords: آنتی ژن اختصاصی پروستات; prostatic hyperplasia; arteries; embolization; therapeutic; treatment outcome; therapies; investigational; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; CT; clinical trial; IIEF; International Index of Erectile Function; ITT; intent to
Keywords: آنتی ژن اختصاصی پروستات; prostatectomy; robotic surgical procedures; comparative effectiveness research; propensity score; ADT; androgen deprivation therapy; ORP; open radical prostatectomy; PCa; prostate cancer; PSA; prostate specific antigen; RARP; robot-assisted radical prosta
Keywords: آنتی ژن اختصاصی پروستات; Piperazine derivatives; MTT assay; α1A blocking activity; Pharmacokinetics; BPH; Benign prostatic hyperplasia; T; testosterone; DHT; dihydrotestosterone; SARM; selective androgen receptor modulator; PSA; prostate specific antigen; MTT; 3-(4, 5-dimethylth
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostatectomy; neoplasm staging; mortality; prostate-specific antigen; AJCC; American Joint Committee on Cancer; BCR; biochemical recurrence; bRFS; biochemical recurrence-free survival; CSS; cancer specific survival; GG; Grade Group;
Keywords: آنتی ژن اختصاصی پروستات; ADT; androgen deprivation therapy; AR; androgen receptor; ASO; antisense oligonucleotide; CARN; castration-resistant Nkx3.1 expressing cells; CK; cytokeratin; CRPC; castration-resistant prostate cancer; DMBA; 7,12-dimethylbenz[a]anthracene; ECM; extracell
Keywords: آنتی ژن اختصاصی پروستات; Prostate specific antigen; Prostate cancer screening; Healthcare utilization; Population health;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; diagnosis; biopsy; depression; anxiety; PCa; prostate cancer/carcinoma; PSA; prostate specific antigen; TRPB; transrectal prostate biopsy;
Keywords: آنتی ژن اختصاصی پروستات; Follow-up; General practitioner; Primary care; Prostate cancer; Prostate specific antigen; Radical prostatectomy;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; neoplasm grading; prostate-specific antigen; continental population groups; BMI; body mass index; NCCN®; National Comprehensive Cancer Network®; PCa; prostate cancer; PSA; prostate specific antigen; PSAD; PSA density; PSAM; PSA mass
Keywords: آنتی ژن اختصاصی پروستات; Prostate cancer; Prostate specific antigen; Prostate needle biopsy; Cancer de la prostate; Antigène prostatique; Biopsie prostatique;
Keywords: آنتی ژن اختصاصی پروستات; recurrence; prostate-specific antigen; prostatectomy; BCR; biochemical recurrence; CaP; prostate cancer; PSA; prostate specific antigen; RP; radical prostatectomy; SP; systemic progression;
Keywords: آنتی ژن اختصاصی پروستات; prostatic hyperplasia; laser therapy; volatilization; ambulatory surgical procedures; anesthesia; local; BPH; benign prostatic hyperplasia; ED; erectile dysfunction; KTP; potassium titanyl phosphate; OAB; overactive bladder; PSA; prostate specific antigen
Keywords: آنتی ژن اختصاصی پروستات; Age; Benign prostatic hyperplasia; Indonesian men; Prostate specific antigen; Prostate volume
Keywords: آنتی ژن اختصاصی پروستات; Biomarker; Diagnosis; Prostate cancer; Prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; prostate; prostate specific antigen; mass screening; African American; educationHCP, health care provider; NHW, nonHispanic white; PCa, prostate cancer; PSA, prostate specific antigen; USPSTF, United States Preventive Services Task Force
Keywords: آنتی ژن اختصاصی پروستات; Evolution; Prostate biopsy; Prostate cancer; Prostate specific antigen; Transrectal ultrasoundEvolución; Biopsia prostática; Cáncer de próstata; Antígeno específico de la próstata; Ecografía transrectal
Keywords: آنتی ژن اختصاصی پروستات; prostate-specific antigen; prostatic neoplasms; recurrence; prostatectomy; BCR; biochemical recurrence; LOQ; limit of quantitation; PSA; prostate specific antigen; RP; radical prostatectomy;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; SEER program; United States/epidemiology; watchful waiting; early detection of cancer; BLS; Bureau of Labor Statistics; CM; conservative management; CPI; Consumer Price Index; NCCN®; National Comprehensive Cancer Network®; PCa; pros
Keywords: آنتی ژن اختصاصی پروستات; Choline; Methyl; Prostate cancer; Sphingomyelin; Statin; BPH; benign prostatic hyperplasia; DMG; dimethylglycine; LDL; low density lipoproteins; Lyso-PtdCho; lysophosphatidylcholine; PCa; prostate cancer; PtdCho; phosphatidylcholine; PtdEth; phosphatidyle
Keywords: آنتی ژن اختصاصی پروستات; Cancer biomarker; Capillary conditioning; Capillary electrophoresis; Isoform; Prostate specific antigen; PSA